Rechallenge of afatinib for EGFR -mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
Article in Translational Lung Cancer Research (June 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Translational Lung Cancer Research (June 2023)
Article in Thoracic Cancer (April 2022)
Article in Frontiers in Oncology (January 2022)